Multidrug-resistant tuberculosis in Australia and our region MDR-TB threatens TB control programs in Australia's region and will not diminish without concerted efforts

被引：7
|
作者：
Trauer, James M. [1 ]
Cheng, Allen C. [1 ,2 ]
机构：
[1] Monash Univ, Melbourne, Vic, Australia
[2] Alfred Hlth, Melbourne, Vic, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2016年 / 204卷 / 07期
关键词：
OUTCOMES;
D O I：
10.5694/mja16.00012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / +
页数：3
相关论文
共 3 条
  • [1] Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Kibuule, Dan
    Godman, Brian
    Hassali, Mohamed Azmi
    Ali, Hamdan Mustafa Hamdan
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (11) : 927 - 937
  • [2] The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia
    Shibabaw, Agumas
    Gelaw, Baye
    Gebreyes, Wondwossen
    Robinson, Richard
    Wang, Shu-Hua
    Tessema, Belay
    PLOS ONE, 2020, 15 (02):
  • [3] Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
    Lee, Myungsun
    Mok, Jeongha
    Kim, Deog Kyeom
    Shim, Tae Sun
    Koh, Won-Jung
    Jeon, Doosoo
    Lee, Taehoon
    Lee, Seung Heon
    Kim, Ju Sang
    Park, Jae Seuk
    Lee, Ji Yeon
    Kim, Song Yee
    Lee, Jae Ho
    Jo, Kyung-Wook
    Jhun, Byung Woo
    Kang, Young Ae
    Ahn, Joong Hyun
    Kim, Chang-Ki
    Shin, Soyoun
    Song, Taeksun
    Shin, Sung Jae
    Kim, Young Ran
    Ahn, Heejung
    Hahn, Seokyung
    Won, Ho Jeong
    Jang, Ji Yeon
    Cho, Sang Nae
    Yim, Jae-Joon
    TRIALS, 2019, 20 (1)
1